In the last trading session, 1.02 million shares of the Nurix Therapeutics Inc (NASDAQ:NRIX) were traded, and its beta was 2.02. Most recently the company’s share price was $13.59, and it changed around -$0.85 or -5.89% from the last close, which brings the market valuation of the company to $806.16M. NRIX currently trades at a discount to its 52-week high of $18.12, offering almost -33.33% off that amount. The share price’s 52-week low was $4.22, which indicates that the current value has risen by an impressive 68.95% since then. We note from Nurix Therapeutics Inc’s average daily trading volume that its 3-month average coming to 979.94K.

Nurix Therapeutics Inc (NASDAQ:NRIX) trade information

Instantly NRIX has showed a red trend with a performance of -5.89% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 31.69% year-to-date, but still down -18.82% over the last five days. On the other hand, Nurix Therapeutics Inc (NASDAQ:NRIX) is 2.33% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $25.25, which translates to bulls needing to increase their stock price by 46.18% from its current value. Analyst projections state that NRIX is forecast to be at a low of $23 and a high of $28.

Nurix Therapeutics Inc (NRIX) estimates and forecasts

Nurix Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 157.39 percent over the past six months and at a -18.87% annual growth rate that is well below the industry average of 13.30%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -59.00%.

NRIX Dividends

Nurix Therapeutics Inc’s next quarterly earnings report is expected to be released around July 11 and July 15.